HEADER DNA BINDING PROTEIN 30-NOV-15 5F1R
TITLE THE TRANSCRIPTIONAL REGULATOR PRFA FROM LISTERIA MONOCYTOGENES IN
TITLE 2 COMPLEX WITH A RING-FUSED 2-PYRIDONE (C10)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: LISTERIOLYSIN REGULATORY PROTEIN;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: TRANSCRIPTION REGULATORY PROTEIN PRFA;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: LISTERIA MONOCYTOGENES SEROVAR 1/2A (STRAIN
SOURCE 3 ATCC BAA-679 / EGD-E);
SOURCE 4 ORGANISM_TAXID: 169963;
SOURCE 5 GENE: PRFA, LMO0200;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS DNA BINDING PROTEIN, PRFA, 2-PYRIDONES, VIRULENCE
EXPDTA X-RAY DIFFRACTION
AUTHOR A.BEGUM,C.GRUNDSTROM,J.A.D.GOOD,C.ANDERSSON,F.ALMQVIST,J.JOHANSSON,
AUTHOR 2 U.H.SAUER,A.E.SAUER-ERIKSSON
REVDAT 4 10-JAN-24 5F1R 1 REMARK
REVDAT 3 13-SEP-17 5F1R 1 REMARK
REVDAT 2 30-MAR-16 5F1R 1 JRNL
REVDAT 1 16-MAR-16 5F1R 0
JRNL AUTH J.A.GOOD,C.ANDERSSON,S.HANSEN,J.WALL,K.S.KRISHNAN,A.BEGUM,
JRNL AUTH 2 C.GRUNDSTROM,M.S.NIEMIEC,K.VAITKEVICIUS,E.CHORELL,
JRNL AUTH 3 P.WITTUNG-STAFSHEDE,U.H.SAUER,A.E.SAUER-ERIKSSON,F.ALMQVIST,
JRNL AUTH 4 J.JOHANSSON
JRNL TITL ATTENUATING LISTERIA MONOCYTOGENES VIRULENCE BY TARGETING
JRNL TITL 2 THE REGULATORY PROTEIN PRFA.
JRNL REF CELL CHEM BIOL V. 23 404 2016
JRNL REFN ESSN 2451-9456
JRNL PMID 26991105
JRNL DOI 10.1016/J.CHEMBIOL.2016.02.013
REMARK 2
REMARK 2 RESOLUTION. 2.25 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.58
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 3 NUMBER OF REFLECTIONS : 24400
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.203
REMARK 3 R VALUE (WORKING SET) : 0.198
REMARK 3 FREE R VALUE : 0.259
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.160
REMARK 3 FREE R VALUE TEST SET COUNT : 1991
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 57.5800 - 5.4219 0.99 1642 150 0.1682 0.2136
REMARK 3 2 5.4219 - 4.3040 1.00 1620 144 0.1604 0.2083
REMARK 3 3 4.3040 - 3.7600 0.99 1621 136 0.1741 0.2405
REMARK 3 4 3.7600 - 3.4163 1.00 1604 147 0.2011 0.2832
REMARK 3 5 3.4163 - 3.1715 1.00 1596 152 0.2315 0.3136
REMARK 3 6 3.1715 - 2.9845 0.99 1585 142 0.2289 0.2823
REMARK 3 7 2.9845 - 2.8350 0.99 1602 139 0.2214 0.2869
REMARK 3 8 2.8350 - 2.7116 0.99 1617 128 0.2123 0.2913
REMARK 3 9 2.7116 - 2.6072 1.00 1593 148 0.2388 0.3265
REMARK 3 10 2.6072 - 2.5173 0.99 1595 144 0.2339 0.3117
REMARK 3 11 2.5173 - 2.4385 0.99 1585 144 0.2646 0.3602
REMARK 3 12 2.4385 - 2.3688 0.99 1604 134 0.3140 0.3611
REMARK 3 13 2.3688 - 2.3065 0.99 1584 152 0.3405 0.3519
REMARK 3 14 2.3065 - 2.2502 0.97 1561 131 0.3827 0.4495
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.240
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 60.30
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 80.00
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.014 3906
REMARK 3 ANGLE : 1.463 5283
REMARK 3 CHIRALITY : 0.073 576
REMARK 3 PLANARITY : 0.012 650
REMARK 3 DIHEDRAL : 10.513 3637
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5F1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-DEC-15.
REMARK 100 THE DEPOSITION ID IS D_1000215837.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 21-FEB-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.5-6.5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID29
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.914
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24400
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250
REMARK 200 RESOLUTION RANGE LOW (A) : 57.580
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2
REMARK 200 DATA REDUNDANCY : 5.600
REMARK 200 R MERGE (I) : 0.05800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9
REMARK 200 DATA REDUNDANCY IN SHELL : 5.50
REMARK 200 R MERGE FOR SHELL (I) : 0.98500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 2BEO
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.40
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PRFA WAS CO-CRYSTALLIZED WITH COMPLEX
REMARK 280 1 (5 MOL EXCESS). CRYSTALS GREW IN 5 DAYS AFTER 1 MICROL OF THE
REMARK 280 PROTEIN SOLUTION (3.5 MG PER ML PRFA, 200 MM NACL, 20 MM NAP
REMARK 280 BUFFER, PH 6.5) WAS MIXED WITH AN EQUAL VOLUME OF PRECIPITANT
REMARK 280 SOLUTION CONTAINING 20% PEG-4000, 16% ISOPROPANOL, 100 MM NA
REMARK 280 CITRATE PH 5.5 AND ALLOWED TO EQUILIBRATE OVER A 1 ML SOLUTION
REMARK 280 OF THE PRECIPITANT IN A LINBRO PLATE. BEFORE DATA COLLECTION,
REMARK 280 THE CRYSTALS WERE TRANSFERRED TO A CRYO-PROTECTANT SOLUTION
REMARK 280 INCLUDING 16% GLYCEROL IN THE PRECIPITANT SOLUTION., VAPOR
REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.48500
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4410 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 20620 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 TYR A 176
REMARK 465 SER A 177
REMARK 465 SER A 178
REMARK 465 GLY A 179
REMARK 465 ILE A 180
REMARK 465 ALA A 181
REMARK 465 HIS A 182
REMARK 465 MET B 1
REMARK 465 TYR B 176
REMARK 465 SER B 177
REMARK 465 SER B 178
REMARK 465 GLY B 179
REMARK 465 ILE B 180
REMARK 465 ALA B 181
REMARK 465 HIS B 182
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE2 GLU B 6 HH TYR B 42 1.52
REMARK 500 OD1 ASN A 15 HZ1 LYS A 108 1.57
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 CYS A 205 CB - CA - C ANGL. DEV. = 7.7 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 25 -6.13 83.42
REMARK 500 SER A 184 -70.15 -58.16
REMARK 500 LYS B 25 -5.62 80.55
REMARK 500 ALA B 218 53.14 -145.79
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 42O A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 42O B 301
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2BEO RELATED DB: PDB
REMARK 900 2BEO CONTAINS THE NATIVE PROTEIN
DBREF 5F1R A 1 237 UNP P22262 PRFA_LISMO 1 237
DBREF 5F1R B 1 237 UNP P22262 PRFA_LISMO 1 237
SEQRES 1 A 237 MET ASN ALA GLN ALA GLU GLU PHE LYS LYS TYR LEU GLU
SEQRES 2 A 237 THR ASN GLY ILE LYS PRO LYS GLN PHE HIS LYS LYS GLU
SEQRES 3 A 237 LEU ILE PHE ASN GLN TRP ASP PRO GLN GLU TYR CYS ILE
SEQRES 4 A 237 PHE LEU TYR ASP GLY ILE THR LYS LEU THR SER ILE SER
SEQRES 5 A 237 GLU ASN GLY THR ILE MET ASN LEU GLN TYR TYR LYS GLY
SEQRES 6 A 237 ALA PHE VAL ILE MET SER GLY PHE ILE ASP THR GLU THR
SEQRES 7 A 237 SER VAL GLY TYR TYR ASN LEU GLU VAL ILE SER GLU GLN
SEQRES 8 A 237 ALA THR ALA TYR VAL ILE LYS ILE ASN GLU LEU LYS GLU
SEQRES 9 A 237 LEU LEU SER LYS ASN LEU THR HIS PHE PHE TYR VAL PHE
SEQRES 10 A 237 GLN THR LEU GLN LYS GLN VAL SER TYR SER LEU ALA LYS
SEQRES 11 A 237 PHE ASN ASP PHE SER ILE ASN GLY LYS LEU GLY SER ILE
SEQRES 12 A 237 CYS GLY GLN LEU LEU ILE LEU THR TYR VAL TYR GLY LYS
SEQRES 13 A 237 GLU THR PRO ASP GLY ILE LYS ILE THR LEU ASP ASN LEU
SEQRES 14 A 237 THR MET GLN GLU LEU GLY TYR SER SER GLY ILE ALA HIS
SEQRES 15 A 237 SER SER ALA VAL SER ARG ILE ILE SER LYS LEU LYS GLN
SEQRES 16 A 237 GLU LYS VAL ILE VAL TYR LYS ASN SER CYS PHE TYR VAL
SEQRES 17 A 237 GLN ASN LEU ASP TYR LEU LYS ARG TYR ALA PRO LYS LEU
SEQRES 18 A 237 ASP GLU TRP PHE TYR LEU ALA CYS PRO ALA THR TRP GLY
SEQRES 19 A 237 LYS LEU ASN
SEQRES 1 B 237 MET ASN ALA GLN ALA GLU GLU PHE LYS LYS TYR LEU GLU
SEQRES 2 B 237 THR ASN GLY ILE LYS PRO LYS GLN PHE HIS LYS LYS GLU
SEQRES 3 B 237 LEU ILE PHE ASN GLN TRP ASP PRO GLN GLU TYR CYS ILE
SEQRES 4 B 237 PHE LEU TYR ASP GLY ILE THR LYS LEU THR SER ILE SER
SEQRES 5 B 237 GLU ASN GLY THR ILE MET ASN LEU GLN TYR TYR LYS GLY
SEQRES 6 B 237 ALA PHE VAL ILE MET SER GLY PHE ILE ASP THR GLU THR
SEQRES 7 B 237 SER VAL GLY TYR TYR ASN LEU GLU VAL ILE SER GLU GLN
SEQRES 8 B 237 ALA THR ALA TYR VAL ILE LYS ILE ASN GLU LEU LYS GLU
SEQRES 9 B 237 LEU LEU SER LYS ASN LEU THR HIS PHE PHE TYR VAL PHE
SEQRES 10 B 237 GLN THR LEU GLN LYS GLN VAL SER TYR SER LEU ALA LYS
SEQRES 11 B 237 PHE ASN ASP PHE SER ILE ASN GLY LYS LEU GLY SER ILE
SEQRES 12 B 237 CYS GLY GLN LEU LEU ILE LEU THR TYR VAL TYR GLY LYS
SEQRES 13 B 237 GLU THR PRO ASP GLY ILE LYS ILE THR LEU ASP ASN LEU
SEQRES 14 B 237 THR MET GLN GLU LEU GLY TYR SER SER GLY ILE ALA HIS
SEQRES 15 B 237 SER SER ALA VAL SER ARG ILE ILE SER LYS LEU LYS GLN
SEQRES 16 B 237 GLU LYS VAL ILE VAL TYR LYS ASN SER CYS PHE TYR VAL
SEQRES 17 B 237 GLN ASN LEU ASP TYR LEU LYS ARG TYR ALA PRO LYS LEU
SEQRES 18 B 237 ASP GLU TRP PHE TYR LEU ALA CYS PRO ALA THR TRP GLY
SEQRES 19 B 237 LYS LEU ASN
HET 42O A 301 45
HET 42O B 301 45
HETNAM 42O (3~{R})-8-CYCLOPROPYL-7-(NAPHTHALEN-1-YLMETHYL)-5-
HETNAM 2 42O OXIDANYLIDENE-2,3-DIHYDRO-[1,3]THIAZOLO[3,2-
HETNAM 3 42O A]PYRIDINE-3-CARBOXYLIC ACID
FORMUL 3 42O 2(C22 H19 N O3 S)
FORMUL 5 HOH *22(H2 O)
HELIX 1 AA1 ASN A 2 ASN A 15 1 14
HELIX 2 AA2 ILE A 99 LYS A 108 1 10
HELIX 3 AA3 ASN A 109 TYR A 154 1 46
HELIX 4 AA4 ASP A 167 GLY A 175 1 9
HELIX 5 AA5 SER A 184 GLU A 196 1 13
HELIX 6 AA6 ASN A 210 ALA A 218 1 9
HELIX 7 AA7 ALA A 218 CYS A 229 1 12
HELIX 8 AA8 CYS A 229 LYS A 235 1 7
HELIX 9 AA9 ALA B 3 ASN B 15 1 13
HELIX 10 AB1 ILE B 99 LYS B 108 1 10
HELIX 11 AB2 ASN B 109 TYR B 154 1 46
HELIX 12 AB3 LEU B 169 GLY B 175 1 7
HELIX 13 AB4 SER B 184 GLU B 196 1 13
HELIX 14 AB5 ASN B 210 ALA B 218 1 9
HELIX 15 AB6 ALA B 218 CYS B 229 1 12
HELIX 16 AB7 CYS B 229 LEU B 236 1 8
SHEET 1 AA1 4 PRO A 19 HIS A 23 0
SHEET 2 AA1 4 GLN A 91 LYS A 98 -1 O ALA A 94 N LYS A 20
SHEET 3 AA1 4 TYR A 37 ASP A 43 -1 N CYS A 38 O ILE A 97
SHEET 4 AA1 4 PHE A 67 MET A 70 -1 O ILE A 69 N ILE A 39
SHEET 1 AA2 4 LEU A 27 PHE A 29 0
SHEET 2 AA2 4 ASN A 84 VAL A 87 -1 O LEU A 85 N PHE A 29
SHEET 3 AA2 4 ILE A 45 ILE A 51 -1 N LYS A 47 O GLU A 86
SHEET 4 AA2 4 ILE A 57 LYS A 64 -1 O GLN A 61 N LEU A 48
SHEET 1 AA3 4 GLY A 155 THR A 158 0
SHEET 2 AA3 4 GLY A 161 ILE A 164 -1 O GLY A 161 N THR A 158
SHEET 3 AA3 4 CYS A 205 VAL A 208 -1 O VAL A 208 N ILE A 162
SHEET 4 AA3 4 ILE A 199 LYS A 202 -1 N VAL A 200 O TYR A 207
SHEET 1 AA4 4 LYS B 20 HIS B 23 0
SHEET 2 AA4 4 GLN B 91 LYS B 98 -1 O ALA B 94 N LYS B 20
SHEET 3 AA4 4 TYR B 37 ASP B 43 -1 N TYR B 42 O THR B 93
SHEET 4 AA4 4 PHE B 67 MET B 70 -1 O ILE B 69 N ILE B 39
SHEET 1 AA5 4 LEU B 27 PHE B 29 0
SHEET 2 AA5 4 ASN B 84 VAL B 87 -1 O LEU B 85 N PHE B 29
SHEET 3 AA5 4 ILE B 45 ILE B 51 -1 N THR B 49 O ASN B 84
SHEET 4 AA5 4 ILE B 57 LYS B 64 -1 O TYR B 63 N THR B 46
SHEET 1 AA6 4 GLY B 155 THR B 158 0
SHEET 2 AA6 4 GLY B 161 ILE B 164 -1 O GLY B 161 N THR B 158
SHEET 3 AA6 4 CYS B 205 VAL B 208 -1 O PHE B 206 N ILE B 164
SHEET 4 AA6 4 ILE B 199 LYS B 202 -1 N LYS B 202 O CYS B 205
CISPEP 1 GLY A 65 ALA A 66 0 5.20
CISPEP 2 GLY B 65 ALA B 66 0 -0.55
SITE 1 AC1 8 GLN A 61 TYR A 62 LYS A 64 TYR A 126
SITE 2 AC1 8 ILE A 149 TRP A 224 HOH A 412 HOH A 413
SITE 1 AC2 9 PHE A 134 LEU B 60 GLN B 61 TYR B 62
SITE 2 AC2 9 TYR B 126 SER B 127 LYS B 130 PHE B 131
SITE 3 AC2 9 SER B 142
CRYST1 56.340 80.970 62.340 90.00 112.54 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017749 0.000000 0.007367 0.00000
SCALE2 0.000000 0.012350 0.000000 0.00000
SCALE3 0.000000 0.000000 0.017368 0.00000